Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

Insulin degludec has a duration of action exceeding 42 hours. What structural modification of native insulin accounts for this ultra-long action?

  • A Addition of a polyethylene glycol (PEGylation) to delay renal clearance
  • B Removal of ThrB30 and attachment of a C16 fatty acid chain to LysB29 via a glutamic acid spacer, enabling multi-hexamer formation and gradual absorption
  • C Substitution of HisB10 with Asp, reducing zinc-binding and preventing hexamer formation
  • D Addition of two extra arginines at the B-chain C-terminus and substitution of Asn at A21 with Gly, shifting the isoelectric point
Correct answer: B. Removal of ThrB30 and attachment of a C16 fatty acid chain to LysB29 via a glutamic acid spacer, enabling multi-hexamer formation and gradual absorption

Explanation

Insulin degludec has ThrB30 deleted and a C16 fatty diacid chain attached to LysB29 via a gamma-glutamic acid linker. In the subcutaneous depot, it self-assembles into large soluble multi-hexamer chains held together by zinc and fatty acid interactions. These gradually dissociate and absorb as monomers, producing a flat, peakless, >42-hour action profile. Option D describes insulin glargine's modifications.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →